Search Ontology:
ChEBI

TAK-733

Term ID
CHEBI:231366
Synonyms
  • (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
  • 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
  • 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodo-phenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidine-4,7-dione
  • TAK 733
  • TAK733
Definition
A member of the class of pyridopyrimidines that is pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione substituted by (2R)-2,3-dihydroxypropyl, (2-fluoro-4-iodophenyl)amino, fluoro, and methyl groups at positions 3, 5, 6, and 8, respectively. It is a non-ATP competitive allosteric inhibitor of MEK1/2.
References
  • cas:1035555-63-5
  • drugbank:DB12241
  • pdb-ccd:IZG
  • pubmed:21310613
  • pubmed:22515704
  • pubmed:25376610
  • pubmed:26014721
  • pubmed:26439693
  • pubmed:26918363
  • pubmed:27650277
  • pubmed:28258008
  • pubmed:29674718
  • pubmed:30396931
  • pubmed:30714951
  • pubmed:33327491
  • pubmed:34534577
  • pubmed:35269397
  • pubmed:38027011
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from TAK-733
Phenotype where environments contain TAK-733
Phenotype modified by environments containing TAK-733
Phenotype affecting TAK-733
Human Disease Model